Category Archives: Sur-spécialités
Webinar: Healing the Ocular Surface: What’s New for Neurotrophic Keratitis
Avr 24th, 2020
Eye & Contact Lens Association (ECLA) presents a Special Symposium 2020 entitled Healing the Ocular Surface: What’s New for Neurotrophic Keratitis that will take place as a webinar on Saturday, May 2, 2020. Moderators Vishal Jhanji, MD: Program Chair, ECLA Deborah S. Jacobs, MD: Executive Committee, ECLA Bennie H. Jeng, MD: Editor-in-Chief, Eye and Contact […]
Retina Connect Weekly Live Webinar Schedule
Avr 23rd, 2020
Download the full Retina Connect Schedule
Treating Glaucoma Patients During COVID-19 in Canada
Avr 22nd, 2020
A case-based webinar to provide up-to-date guidance in the management of glaucoma patients during COVID-19
Webinar – DOVS GRAND ROUNDS A Paradigm Shift in Retinal Detachment Repair
Avr 22nd, 2020
Apr 24, 2020 | 12:00pm–1:30pm GRAND ROUNDS DETAILS TOPIC: A Paradigm Shift in Retinal Detachment Repair SPEAKER: Dr. Rajeev Muni Objectives 1) To understand how retinal detachment surgery has evolved over the past several decades. 2) To understand the role of multimodal imaging in optimizing functional outcomes following retinal detachment repair. 3) To understand how integrity […]
RESIDENT TEACHING: Retinopathy of Prematurity, PHPV and Ped Retina Cases AND Phakomatoses/Angiomatous Tumors
Avr 22nd, 2020
Friday April 24 – 9:30 AM – 11:30 AM Topic: Retinopathy of Prematurity, PHPV and Ped Retina Cases AND Phakomatoses/Angiomatous Tumors Speaker: Drs. Nasrin Tehrani and Keyvan Koushan Access Details Zoom link – https://zoom.us/j/95087961248?pwd=MlZPTmtka0RRWTAyQlhadGZOZnp5QT09 Password: 9rz3LF
Recommandations de la Société canadienne du glaucome pour la prestation de soins oculovisuels aux patients atteints de glaucome pendant la pandémie de COVID-19
Avr 21st, 2020
16 avril 2020 Contexte La pandémie de COVID-19 a mené à la mise en œuvre généralisée de mesures d’isolement physique et à l’arrêt des consultations et des interventions médicales non urgentes. Ce document vise à aider les médecins qui s’occupent de patients atteints de glaucome à atténuer le risque, tant pour les patients que pour les fournisseurs […]
Énoncé de principe de la Société canadienne de la rétine (SCR) sur les injections intravitréennes et la gestion des maladies rétiniennes pendant la crise de la COVID-19
Avr 20th, 2020
Le 19 mars 2020 Contexte Le Comité exécutif de la SCR a examiné les recommandations émanant des groupes locaux, nationaux et internationaux en médecine et en ophtalmologie au sujet de la gestion des patients et des risques pour les travailleurs de la santé pendant cette crise de la COVID. La SCR fournit les commentaires ci-après. Ces commentaires […]
Webinar – Retina Connect: Residual fluid following intravitreal injections – what does it mean? what do we do?
Avr 17th, 2020
The University of Toronto, Department of Ophthalmology and Vision Sciences invites you to RETINA CONNECT. DATE: Tuesday April 21, 2020 4pm EST TOPIC: Residual fluid following intravitreal injections – what does it mean? what do we do? » SPEAKER: Sadda, MD, President, Doheny Eye Institute, Chair and Professor of Ophthalmology, UCLA Geffen School of Medicine Panelists […]